Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Dilini Christina Ranasinghe: An Exception to the ‘Universal Donor’ – Bombay (Oh)
Dilini Christina Ranasinghe/LinkedIn
Sep 5, 2026, 11:29

Dilini Christina Ranasinghe: An Exception to the ‘Universal Donor’ – Bombay (Oh)

Dilini Christina Ranasinghe, Registrar in Transfusion Medicine at National Blood Centre, shared a post on LinkedIn:

“An Exception to the ‘Universal Donor’: Bombay (Oh)

A 68-year-old woman with myocardial infarction and a haemoglobin of 5.6 g/dL was referred to the Immunohaematology Reference Laboratory following positive antibody screening and difficulty obtaining crossmatch-compatible blood.

Her forward group appeared to be O.

However:

  • Reverse grouping showed strongly positive reactions with A₁, B and O cells.
  • Reactivity remained strongly positive at 37 degrees Celsius.
  • Antibody screening was panreactive at strongly positive.
  • Her red cells did not react with anti-H lectin, while known group O cells reacted at 4+.

The findings were consistent with the Bombay (Oh) phenotype.

Anti-H is the key transfusion hazard; ordinary group O red cells are therefore unsafe.

Fortunately, a Bombay (Oh) red-cell unit, which was IAT crossmatch compatible, was available in stock.

But what if it had not been?

Sri Lanka’s centrally coordinated blood transfusion service and rare-donor registry allow islandwide donor mobilisation.

Nevertheless, identifying an eligible donor, arranging collection and testing, and transporting the unit all take time – time that an acutely ill patient may not have.

For elective procedures, early planning is essential:

  • Activate the rare-donor registry.
  • Screen siblings and other family members for potential compatible donors.
  • Coordinate donations carefully with the blood service.
  • Optimise the patient and minimise blood loss through patient blood management.

Family screening does not replace donor eligibility assessment or compatibility testing.

Cellular components donated by relatives must also be irradiated.

Rare blood saves lives – but only when recognition, planning and donor coordination come together.”

Dilini Christina Ranasinghe

Find more posts featuring Dilini Christina Ranasinghe on Hemostasis Today.

Anti-H Blood Blood donation Bombay Blood Group Bombay phenotype Dilini Christina Ranasinghe Health Hematology Hemostasis Hemostasis News Hemostasis Today IAT Medicine Plasma Donation RBC
NewsFeed